Physician profile
John D Baker
NPI 1124022850
$3,733.74
in general payments reported to CMS, 2019-2025
17 companies · $378 in 2025
The $378 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,964 · 2020: $19.99 · 2021: $280 · 2022: $379 · 2023: $248 · 2024: $465 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $945 · Consulting Fee: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $945.28 |
| Consulting Fee | $145.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,280.15 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $363.55 | 2019-2024 | Brilinta |
| Novartis Pharmaceuticals Corporation | $301.37 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $249.64 | 2019-2023 | Lifevest |
| Amgen INC. | $244.56 | 2024 | Repatha |
| Shockwave Medical, INC | $225.13 | 2025 | |
| Abbott Laboratories | $151.32 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $130.31 | 2023 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.99 | 2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $117.82 | 2025 | Camzyos |
| Amarin Pharma, INC. | $117.77 | 2019 | |
| Edwards Lifesciences Corporation | $95.36 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Merck Sharp & Dohme LLC | $92.59 | 2022 | |
| Abiomed | $81.20 | 2022-2025 | |
| Biotronik INC. | $76.09 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $62.40 | 2021 | |
| Kestra Medical Technology Services, INC. | $19.49 | 2024 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.